Loxo Oncology, Inc. Retained Earnings
Loxo Oncology, Inc. had Retained Earnings of -$330.46 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-11-08
- 2018-09-30: Retained Earnings (Accumulated Deficit) -$330.46M.
- 2018-06-30: Retained Earnings (Accumulated Deficit) -$303.40M.
- 2018-03-31: Retained Earnings (Accumulated Deficit) -$291.67M.
- 2017-12-31: Retained Earnings (Accumulated Deficit) -$288.11M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2018-09-30 | -$330.46M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$303.40M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$291.67M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$288.11M 10-Q · filed 2018-11-08 |
| 2017-09-30 | -$267.48M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$194.16M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$163.76M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$139.24M 10-K · filed 2018-03-01 |
| 2016-09-30 | -$112.04M 10-Q · filed 2016-11-02 |
| 2016-06-30 | -$94.35M 10-Q · filed 2016-08-03 |
| 2016-03-31 | -$78.44M 10-Q · filed 2016-05-04 |
| 2015-12-31 | -$66.84M 10-K · filed 2017-03-07 |
| 2015-09-30 | -$53.97M 10-Q · filed 2015-11-10 |
| 2015-06-30 | -$45.20M 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$37.14M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$30.96M 10-K · filed 2016-03-15 |
| 2014-09-30 | -$23.84M 10-Q · filed 2014-11-14 |
| 2014-06-30 | -$17.10M 10-Q · filed 2014-10-07 |
| 2013-12-31 | -$10.29M 10-K · filed 2015-03-27 |